Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

shutterstock_292920209

UCB and Biogen’s lupus drug falls short at Phase 2b

October 24, 2018 Research and Development Biogen, Lupus, UCB, dapirolizumab pegol, pharma, systemic lupus erythematosus, trial falure

The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet …
News
acute_lymphoblastic_leukaemia_smear

New $2 million programme aims at increasing diversity in cancer research

October 24, 2018 Research and Development Cancer, USA, black, cancer research, diversity, latino, native american

The National Cancer Institute are developing a joint cancer drug discovery and development, and research education programme focused towards the …
News
shutterstock_360472550

Pfizer & Lilly’s non-opioid drug reduces pain in osteoarthritis

October 24, 2018 Research and Development Eli Lilly, Pfizer, osteoarthritis, pharma

Pfizer and Eli Lilly have announced data revealing that their nerve growth factor (NGF) inhibitor tanezumab met all three of …
News
28246711066_52e38bc591_z

Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit

October 24, 2018 Research and Development brexit, no-deal Brexit, stockpiling

Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) …
News
tibet-3591529_960_720

Guangdong bans transportation of pigs due to African swine fever outbreak in Hunan

October 23, 2018 Research and Development ASF, African swine fever, China, Guangdong, Hunan, animal health

Chinese authorities have banned the transportation of live pigs from Guangdong to other regions, after reports of African swine fever …
News
roche

Roche’s Alecensa topples Pfizer’s Xalkori in Asian patients with ALK+ advanced lung cancer

October 23, 2018 Manufacturing and Production, Research and Development Alecensa, Cancer, ESMO 2018, Roche, lung cancer, pharma

Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small …
News
merckincweb2

First-line Keytruda shows better overall survival in head & neck cancer

October 23, 2018 Manufacturing and Production, Research and Development Cancer, ESMO 2018, MSD, head and neck cancer, keytruda, pharma

MSD’s Keytruda (pembrolizumab) made an impact at the European Society for Medical Oncology 2018 Congress as the company unveiled new …
News
roche_dark_0

Roche’s Tecentriq+chemo boosts survival in first-line non-small cell lung cancer

October 22, 2018 Research and Development, Sales and Marketing Cancer, Roche, lung cancer NSCLC, pharma, tecentriq

Roche joined other major players like Bristol-Myers Squibb in revealing strong data on their cancer immunotherapies at the European Society …
News

Working Life: Joe Wiley, CEO, Amryt Pharma

October 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, CEO, Ireland, Joe WIley, pharma

Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …
Feature
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya maintains skin clearance after 3 years in plaque psoriasis

October 22, 2018 Research and Development, Sales and Marketing Janssen, Tremfya, pharma, plaque psoriasis, psoriasis

Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin …
News
merckincweb

MSD’s Keytruda with Pfizer’s Inlyta beats Sutent in most common kidney cancer

October 19, 2018 Medical Communications, Research and Development Cancer, Kidney cancer, MSD, Pfizer, inlyta, keytruda, pharma

MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …
News
causes_of_hearing_lose_jpg

Hearing loss and inner ear disorders: The next frontier for pharmaceutical success?

October 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sensorion, hearing loss, inner ear disorders, opinion, pharma

Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …
Feature
novartis_window

Novartis snaps up cancer drug developer Endocyte for $2.1 billion

October 18, 2018 Research and Development, Sales and Marketing Cancer, Endocyte, Novartis, pharma

Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology …
News
1920px-hiv-budding-color

Researchers launch Phase 1 trial of HIV vaccine

October 18, 2018 Research and Development AIDS, HIV, Vaccine, infection, resdearch

Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026